In the studies conducted so far, increased levels of AGA antibodies have been observed in approximately 30% of patients with schizophrenia [25,29], but with clinically significant results ranging from 1.43% to 59%, which may be due to the heterogeneity of the groups [21,22,23,25,29]. Here, AGA is linked to schizophrenia.